Back

Impact of Carvedilol versus Bisoprolol on long-term clinical outcomes in STEMI patients with mid-range LVEF

1 September 2025 (10:45 - 10:57)
Organised by: Logo
Congress Presentation Part of: Novel pharmacological approaches following an acute coronary syndrome Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Melly Susanti

Ministry of Health Surabaya Central General Hospital, Jawa Timur (Indonesia)

3 More presentations in this session

Presentation thumbnail
Effect of statins on MACE in patients with coronary artery spasm: a meta-analysis
Mr L. Barbosa (Belo Horizonte, BR)
Abstract Slides
Presentation thumbnail
Vitamin D supplements do not affect adverse left ventricular remodelling after an anterior myocardial infarction
Professor J. Tunon Fernandez (Madrid, ES)
Abstract Slides
Presentation thumbnail
Effect of PCSK9 inhibitors on the quality of life in patients with acute coronary syndromes
Professor J. Gao (Tianjin, CN)
Abstract Slides

Access the full session

Session thumbnail
Novel pharmacological approaches following an acute coronary syndrome
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction
thumbnail
Congress Presentation
Efficacy of early versus late b-blocker administration after primary PCI
thumbnail
Congress Presentation
Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources